Skip to main content

Table 4 Relationship of CS with impairment of blood coagulation and adverse events

From: Impact of intra-operative cell salvage on blood coagulation in high-bleeding-risk patients undergoing cardiac surgery with cardiopulmonary bypass: a prospective randomized and controlled trial

Variable

RR

95 % CI

P value

Heparin residual

6.10

1.14–32.60

0.034

Coagulopathy for low PLT

0.61

0.14–2.61

0.509

Coagulopathy for low FIB

1.35

0.40–4.48

0.629

Coagulopathy for low clotting factors

0.56

0.09–3.30

0.521

Excessive bleeding

4.58

1.02–18.34

0.049

Myocardial infarction

0.15

0.01–1.99

0.150

Cognitive decline

<0.001

<0.001–999.99

0.938

  1. RR relative risk, CI confidence interval